EGFR and glioblastoma: The IC50 of TMZ in EGFR+ cells was significantly increased compared to EGFR− cells (462.7 μM vs. 3062 μM), thus indicating that EGFRvIII expression is related to a reduced sensitivity to TMZ in U87 GBM cells.